// App-Quantinova.ai

: Can free PSA be used as a biomarker in biochemical recurrence after surgery to predict castrate resistant prostate cancer?

Researchers

Presenter

  • Hanan Goldberg

Principal Investigators

  • Ally Hoffman

  • Teck Sing Woon

  • Zachary William Abraham Klaassen

  • Thenappan Chandrasekar

  • Douglas Cheung

  • Alejandro Berlin

  • Rashid Sayyid

  • Neil Eric Fleshner

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Georgia Regents University, August, GA

  • University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A